HOME
Donate now
EN FR
Current language is English. Click to change language
EN FR

Genomic Epidemiology Branch (GEM)

Publications

All recent publications: 2026-2022

View Key Publications

 

  1. Moore A, Kane E, Teras LR, Machiela MJ, Arias J, Panagiotou OA, et al. (2026). Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses. Int J Cancer. 158(1): 45-59. https://doi.org/10.1002/ijc.70039 PMID: 40910475
  2. Rumgay H, Colombet M, Ramos da Cunha A, Filho AM, Warnakulasuriya S, Conway DI, et al. (2026). Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022. CA Cancer J Clin. 76(1). https://doi.org/10.3322/caac.70048 PMID: 41335400
  3. Berstein FM, Khouja J, Gormley M, Ebrahimi E, Virani S, McKay JD, et al. (2025). Reassessing the link between adiposity and head and neck cancer: a Mendelian randomization study. Elife. 14: RP106075. https://doi.org/10.7554/eLife.106075
  4. Bina F, Bani F, Khalilzadeh B, Gheit T, Karimi A (2025). Advancements in fluorescent nanobiosensors for HPV detection: from integrating nanomaterials to DNA nanotechnology. Int J Biol Macromol. 311(Pt 1): 143619. https://doi.org/10.1016/j.ijbiomac.2025.143619 PMID: 40306516
  5. Boccacino JM, Del Castillo Velasco-Herrera M, Beale MA, Billington J, Vermes I, Obolenski S, et al. (2025). SPARKI: a tool for the statistical analysis of pathogen identification results. Bioinformatics. 41(11): btaf596. https://doi.org/10.1093/bioinformatics/btaf596 PMID: 41169153
  6. Boccacino JM, Del Castillo Velasco-Herrera M, Beale MA, Billington J, Vermes I, Obolenski S, et al. (2025). SPARKI: a tool for the statistical analysis of pathogen identification results. Bioinformatics. 41(11). https://doi.org/10.1093/bioinformatics/btaf596 PMID: 41169153
  7. Byun J, Han Y, Choi J, Sun R, Shaw VR, Zhu C, et al. (2025). Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci. Hum Mol Genet. 34(14): 1227-1237. https://doi.org/10.1093/hmg/ddaf059 PMID: 40341939
  8. Cabrera-Serrano AJ, Sanchez-Maldonado JM, Rodriguez-Sevilla JJ, Reyes-Zurita FJ, Collado R, Puiggros A, et al. (2025). Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia. Blood Adv. 9(23): 6076-6089. https://doi.org/10.1182/bloodadvances.2025017345 PMID: 40902075
  9. Centonze G, Maisonneuve P, Mathian E, Grillo F, Sabella G, Lagano V, et al. (2025). Digital Immunophenotyping of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Subtypes With Specific Tumor-Immune Microenvironment Features. Endocr Pathol. 36(1): 39. https://doi.org/10.1007/s12022-025-09886-9 PMID: 41136735
  10. Clay-Gilmour AI, Camp NJ, Wei X, Earle A, Norman A, Sinnwell J, et al. (2025). Whole-Exome Sequencing-Based Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Pedigrees. Cancers (Basel). 17(22). https://doi.org/10.3390/cancers17223611 PMID: 41300981
  11. Creaney G, de Aquino Goulart M, McMahon A, Paterson C, McCaul J, Perdomo S, et al. (2025). Advanced Stage Head and Neck Cancer Diagnosis: HEADSpAcE Consortium Health Systems Benchmarking Survey. Head Neck. 47(7): 1977-1988. https://doi.org/10.1002/hed.28094 PMID: 39994901
  12. da Cunha AR, Rumgay H, Vignat J, Laversanne M, Colombet M, Curado MP, et al. (2025). Global burden and international trends of laryngeal cancer incidence: A population-based study of recorded data and national estimates. Cancer Epidemiol. 99: 102935. https://doi.org/10.1016/j.canep.2025.102935 PMID: 40997398
  13. da Cunha AR, Rumgay H, Vignat J, Laversanne M, Colombet M, Curado MP, et al. (2025). Global burden and international trends of laryngeal cancer incidence: A population-based study of recorded data and national estimates. Cancer Epidemiol. 99: 102935. https://doi.org/10.1016/j.canep.2025.102935 PMID: 40997398
  14. DeMarini DM, Gwinn W, Watkins E, Reisfeld B, Chiu WA, Zeise L, et al. (2025). IARC Workshop on the Key Characteristics of Carcinogens: Assessment of End Points for Evaluating Mechanistic Evidence of Carcinogenic Hazards. Environ Health Perspect. 133(2): 25001. https://doi.org/10.1289/EHP15389 PMID: 39899356
  15. Diaz-Gay M, Dos Santos W, Moody S, Kazachkova M, Abbasi A, Steele CD, et al. (2025). Geographic and age variations in mutational processes in colorectal cancer. Nature. 643(8070): 230-240. https://doi.org/10.1038/s41586-025-09025-8 PMID: 40267983
  16. Diaz-Gay M, Zhang T, Hoang PH, Leduc C, Baine MK, Travis WD, et al. (2025). The mutagenic forces shaping the genomes of lung cancer in never smokers. Nature. 644(8075): 133-144. https://doi.org/10.1038/s41586-025-09219-0 PMID: 40604281
  17. Domingues A, Zhai Y, Parat MO, Viallon V, Degenhardt L, Pearson SA, et al. (2025). Measuring Exposure to Opioids Using Self-Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study. Pharmacoepidemiol Drug Saf. 34(12): e70280. https://doi.org/10.1002/pds.70280 PMID: 41355709
  18. Dong M, Thakral A, Byrne KS, Bosse Y, Zhou H, Zhang Y, et al. (2025). Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium. Carcinogenesis. 46(2). https://doi.org/10.1093/carcin/bgaf031 PMID: 40746155
  19. Ebrahimi E, Naudin S, Dimou N, Mayen AL, Wang M, Abnet CC, et al. (2025). Alcohol consumption and upper aerodigestive tract squamous cell carcinoma: evidence from 28 prospective cohorts. J Natl Cancer Inst. 117(12): 2598-2611. https://doi.org/10.1093/jnci/djaf230 PMID: 40977057
  20. Ebrahimi E, Sangphukieo A, Park HA, Gaborieau V, Ferreiro-Iglesias A, Diergaarde B, et al. (2025). Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites. Nat Commun. 16(1): 8787. https://doi.org/10.1038/s41467-025-63842-z PMID: 41038832
  21. Ecke TH, Le Calvez-Kelm F, van Poppel H (2025). Why We Need More Attention on Bladder Cancer: Establishing Policy Recommendations for Health Care Professionals and Politicians. Eur Urol. 87(5): 504-506. https://doi.org/10.1016/j.eururo.2025.02.005 PMID: 39979171
  22. Eng L, Evans WK, Eisele M, Nishimura KK, Land SR, Rami-Porta R, et al. (2025). The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM Classification. J Thorac Oncol. 20(10): 1441-1458. https://doi.org/10.1016/j.jtho.2025.07.002 PMID: 40920143
  23. Evans WK, Evison M, Sheikh M, Eng L, Ayo-Yusuf O, Shankar A, et al. (2025). Cancer clinical trials should capture tobacco smoking status. Lancet Oncol. 26(8): 990-993. https://doi.org/10.1016/S1470-2045(25)00364-X PMID: 40744029
  24. Feng X, Alcala K, Guida F, Goldberg M, Zins M, Leleu O, et al. (2025). Eligibility criteria for lung cancer screening in France: a modelling study. Lancet Reg Health Eur. 51: 101221. https://doi.org/10.1016/j.lanepe.2025.101221 PMID: 39968190
  25. Fernandez-Cuesta L, Alcala N, Mathian E, Derks J, Thirlwell C, Dayton T, et al. (2025). Basic science and translational implications of current knowledge on neuroendocrine tumors. J Clin Invest. 135(5). https://doi.org/10.1172/JCI186702 PMID: 40026252
  26. Fernandez-Cuesta L, Voegele C, Hemon B, Alcala K, Aune D, Caini S, et al. (2025). The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research. ESMO Rare Cancers. 2: None. https://doi.org/10.1016/j.esmorc.2025.100014 PMID: 40661340
  27. Francis DL, Pape Reddy SS, Rathi M, Chopra SS (2025). From periodontal inflammation to oral cancer: the impact of smokeless tobacco. Lancet Reg Health Southeast Asia. 36: 100574. https://doi.org/10.1016/j.lansea.2025.100574 PMID: 40241691
  28. Francis DL, Reddy SSP, Chopra SS (2025). Oral health considerations in the management of monkeypox. Oral Dis. 31(3): 1030-1031. https://doi.org/10.1111/odi.15126 PMID: 39226179
  29. George GS, Singh A, Moirangthem R, Patil A, Pullat GB, Sagare S, et al. (2025). Association of Decayed, Missing, Filled Teeth Score With the Risk for Buccal Mucosa Cancer, Stratified on Tobacco and Alcohol Use: A Multicenter Case-Control Study From India. JCO Glob Oncol. 11: e2500119. https://doi.org/10.1200/GO-25-00119 PMID: 40700664
  30. Grenville ZS, Noor U, Rinaldi S, Gunter MJ, Ferrari P, Agnoli C, et al. (2025). Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case-control sets from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 156(5): 943-952. https://doi.org/10.1002/ijc.35208 PMID: 39378119
  31. Guo L, Wang L, Cai L, Zhang Y, Feng X, Zhu C, et al. (2025). Global Distribution of Colorectal Cancer Staging at Diagnosis: An Evidence Synthesis. Clin Gastroenterol Hepatol. 23(12): 2088-2101. https://doi.org/10.1016/j.cgh.2024.11.019 PMID: 39694204
  32. Gutierrez M, Zamora I, Iriarte R, Pajares MJ, Yang Q, Qian C, et al. (2025). ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer. Mol Med. 31(1): 232. https://doi.org/10.1186/s10020-025-01267-6 PMID: 40500731
  33. Hasanpour-Heidari S, Semnani S, Fazel A, Naeimi-Tabiei M, Mehrjerdian M, Sedaghat S, et al. (2025). Risk of Second Primary Neoplasms Among Cancer Survivors: A Population-Based, Cohort Study in Golestan Province, Northern Iran, 2004-2019. Cancer Med. 14(10): e70926. https://doi.org/10.1002/cam4.70926 PMID: 40391756
  34. Hassanzadeh-Rangi N, Hosseini B, Akhtari Y, Farvaresh E, Khosravi Y (2025). Profile of Occupational Health Services in Iran: A Mixed-Methods Study Focusing on Service Coverage and Interventions. Journal of Health and Safety at Work. 15(1): 144-173.
  35. Hefteh N, Welch O, Sheikh M, La Caze A, Parat MO (2025). The organ-specific modulation of malignant processes by opioids: a systematic review of cell culture studies. Br J Cancer. 132(12): 1091-1099. https://doi.org/10.1038/s41416-025-03014-4 PMID: 40217097
  36. Keck MK, Tietze A, Bison B, Avula S, Engelhardt J, Faure-Conter C, et al. (2025). Comparative Clinical and Imaging-Based Evaluation of Therapeutic Modalities in CNS Embryonal Tumours With PLAGL Amplification. Neuropathol Appl Neurobiol. 51(2): e70015. https://doi.org/10.1111/nan.70015 PMID: 40196918
  37. Lam ACL, Hueniken K, Pienkowski M, Lee JJW, Dong M, Diergaarde B, et al. (2025). Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 151(4): 360-370. https://doi.org/10.1001/jamaoto.2024.5392 PMID: 39976935
  38. Leunissen DJG, Moonen L, Alcala N, Speel EM, Derks JL (2025). A Response to the Letter to the Editor: “Linear Versus Non-Linear: Debunking Critiques on PCA Use in Molecular Subgrouping of Pulmonary Carcinoids”. J Thorac Oncol. 20(4): e55-e56. https://doi.org/10.1016/j.jtho.2025.01.012 PMID: 40204399
  39. Leunissen DJG, Moonen L, von der Thusen JH, den Bakker MA, Hillen LM, van Weert TJJ, et al. (2025). Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids. J Thorac Oncol. 20(4): 451-464. https://doi.org/10.1016/j.jtho.2024.11.018 PMID: 39581377
  40. Martel A, Raue L, Avogbe PH, Raisch J, Jeldres C, Ecke T, et al. (2025). Urinary biomarkers in multicentric studies: Shaping the future of bladder cancer diagnosis and follow-up. BJUI Compass. 6(12): e70124. https://doi.org/10.1002/bco2.70124 PMID: 41425536
  41. Matta K, Viallon V, Chatziioannou AC, Robinot N, Wedekind R, Dahm CC, et al. (2025). Can serum metabolic signatures inform on the relationship between healthy lifestyle and colon cancer risk? Cancer Metab. 13(1): 30. https://doi.org/10.1186/s40170-025-00388-0 PMID: 40524238
  42. McElderry JP, Zhang T, Zhao W, Hoang PH, Anyaso-Samuel S, Sang J, et al. (2025). Microbiome analysis of 940 lung cancers in never-smokers reveals lack of clinically relevant associations. Nat Commun. 17(1): 192. https://doi.org/10.1038/s41467-025-66780-y PMID: 41387456
  43. McNamara MG, Sorbye H, Begum N, Christ E, Fazio N, Fernandez-Cuesta L, et al. (2025). Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract. J Neuroendocrinol. 37(12): e70080. https://doi.org/10.1111/jne.70080 PMID: 40781987
  44. Moono M, Sharma A, Bohlius J, Mwanahamuntu M, Taghavi K, Mwamba C, et al. (2025). The cervical cancer screening and precancer treatment journey: a qualitative study of experiences among Zambian women living with and without HIV. Oncologist. 31(1). https://doi.org/10.1093/oncolo/oyaf412 PMID: 41389284
  45. Morales Berstein F, Khouja J, Gormley M, Ebrahimi E, Virani S, McKay JD, et al. (2025). Reassessing the link between adiposity and head and neck cancer: a Mendelian randomization study. Elife. 14: RP106075. https://doi.org/10.7554/eLife.106075 PMID: 41065334
  46. Nalini M, Poustchi H, Bhandari D, Blount BC, Kenwood BM, Chang CM, et al. (2025). Exposure to volatile organic compounds and chronic respiratory disease mortality, a case-cohort study. Respir Res. 26(1): 88. https://doi.org/10.1186/s12931-025-03165-1 PMID: 40045272
  47. Naudin S, Wang M, Dimou N, Ebrahimi E, Genkinger J, Adami HO, et al. (2025). Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. PLoS Med. 22(5): e1004590. https://doi.org/10.1371/journal.pmed.1004590 PMID: 40392909
  48. Nazarzadeh M, Copland E, Smith Byrne K, Canoy D, Bidel Z, Woodward M, et al. (2025). Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization Studies. JACC CardioOncol. 7(5): 609-623. https://doi.org/10.1016/j.jaccao.2025.03.005 PMID: 40366326
  49. O’Connell KS, Koromina M, van der Veen T, Boltz T, David FS, Yang JMK, et al. (2025). Genomics yields biological and phenotypic insights into bipolar disorder. Nature. 639(8056): 968-975. https://doi.org/10.1038/s41586-024-08468-9 PMID: 39843750
  50. Onwuka JU, Zahed H, Feng X, Alcala K, Erhunmwunsee L, Williams RM, et al. (2025). Association between socioeconomic position and lung cancer incidence in 16 countries: a prospective cohort consortium study. EClinicalMedicine. 82: 103152. https://doi.org/10.1016/j.eclinm.2025.103152 PMID: 40212049
  51. Pagano I, Zhang Z, Luu M, Tikhonenkov S, Le Calvez-Kelm F, Goodison S, et al. (2025). Performance of the Oncuria-Detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting. J Transl Med. 23(1): 680. https://doi.org/10.1186/s12967-025-06749-z PMID: 40533776
  52. Park JY, Van Puyvelde H, Regazzetti L, Clasen JL, Heath AK, Eussen S, et al. (2025). Association Between Dietary Intake and Blood Concentrations of One-Carbon-Metabolism-Related Nutrients in European Prospective Investigation into Cancer and Nutrition. Nutrients. 17(12): 19. https://doi.org/10.3390/nu17121970 PMID: 40573081
  53. Pittavino M, Plummer M, Johansson M, Riboli E, Ferrari P (2025). A Bayesian hierarchical framework to integrate dietary exposure and biomarker measurements into aetiological models. Journal of the Royal Statistical Society Series C-Applied Statistics. 74(5): 1427-1443. https://doi.org/10.1093/jrsssc/qlaf029
  54. Reddy SSP, Francis DL, Harish R, Raja K, Chopra SS (2025). “Liver Clots” in Periodontology: A 10-Year Clinical Experience. Oral Dis. 31(4): 1268-1276. https://doi.org/10.1111/odi.15190 PMID: 39530339
  55. Reddy SSP, Singh H, Francis DL, Harish R, Rathi M, Karmakar S, et al. (2025). Laser patterned microcoagulation (LPM) in the management of desquamative gingivitis secondary to oral lichen planus: A randomized controlled pilot clinical trial (LPM TRIAL). Lasers Med Sci. 40(1): 188. https://doi.org/10.1007/s10103-025-04454-3 PMID: 40214823
  56. Sampoornam Pape Reddy S, Francis DL, Rathi M, Harish R, Narayana R, Manohar B, et al. (2025). Microsurgical Semilunar Bilaminar Technique Halts Progression of Marginal Tissue Recession by Soft Tissue Phenotypic Modification-A Case Report With 3-Year Follow-Up. Clin Case Rep. 13(1): e70054. https://doi.org/10.1002/ccr3.70054 PMID: 39802367
  57. Serban ST, Perdomo S, Borges-Yanez A, Allen F, Guarnizo-Herreno C, Navarro-Ramirez MK, et al. (2025). The Political Determinants of Oral Health Inequalities: Lessons in Policy Development and Implementation From Six Case Studies. Community Dent Oral Epidemiol. 53(5): 514-532. https://doi.org/10.1111/cdoe.70005 PMID: 40717040
  58. Sheikh M, Domingues A, Alcala K, Langdon R, Mariosa D, Feng X, et al. (2025). Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysis. EClinicalMedicine. 89: 103439. https://doi.org/10.1016/j.eclinm.2025.103439 PMID: 41357337
  59. Sheikh M, Evison M (2025). Treating tobacco dependency in cancer care: essential, cost-effective, and feasible, yet overlooked. Br J Cancer. 132(7): 585-586. https://doi.org/10.1038/s41416-025-02957-y PMID: 39948239
  60. Sheikh M, Weiderpass E (2025). Lung cancer screening in Europe: a golden opportunity to address tobacco use through scalable, WHO-guided cessation interventions. Eur Respir J. 65(6): 5. https://doi.org/10.1183/13993003.00124-2025 PMID: 40537166
  61. Shrestha S, Foot H, Sheikh M, Parat MO, La Caze A (2025). Opioid use and the risk of cancer incidence and mortality: a systematic review. Cancer Metastasis Rev. 44(2): 54. https://doi.org/10.1007/s10555-025-10268-0 PMID: 40498363
  62. Stratton MR, Humphreys L, Alexandrov LB, Balmain A, Brennan P, Campbell PJ, et al. (2025). Implementing Mutational Epidemiology on a Global Scale: Lessons from Mutographs. Cancer Discov. 15(1): 22-27. https://doi.org/10.1158/2159-8290.CD-24-1687 PMID: 39801236
  63. Tang Z, Wang Y, Sarnat JA, Diver WR, Everson TM, Deubler E, et al. (2025). The Associations of Air Pollution Mixture Exposure with Plasma Proteins in an Elderly U.S. Panel. Environ Sci Technol. 59(30): 15692-15704. https://doi.org/10.1021/acs.est.5c03052 PMID: 40704984
  64. Tietze A, Bison B, Engelhardt J, Fenouil T, Figarella-Branger D, Goebell E, et al. (2025). CNS Embryonal Tumor with PLAGL Amplification, a New Tumor in Children and Adolescents: Insights from a Comprehensive MRI Analysis. AJNR Am J Neuroradiol. 46(3): 536-543. https://doi.org/10.3174/ajnr.A8496 PMID: 39271290
  65. Torrens L, Moody S, de Carvalho AC, Kazachkova M, Abedi-Ardekani B, Cheema S, et al. (2025). The complexity of tobacco smoke-induced mutagenesis in head and neck cancer. Nat Genet. 57(4): 884-896. https://doi.org/10.1038/s41588-025-02134-0 PMID: 40164736
  66. Valbuena-Garcia AM, Trujillo-Caceres SJ, Hernandez Vargas JA, Diaz S, Acuna L, Perdomo S, et al. (2025). Quality of care in Colombian women with early-onset breast cancer in two time periods: findings from a nationwide administrative registry cohort. Lancet Reg Health Am. 43: 101018. https://doi.org/10.1016/j.lana.2025.101018 PMID: 40171140
  67. Vicente A, de Souza Santos FA, Hirai WY, Lissa D, de Oliveira Cavagna R, da Silva ALV, et al. (2025). HOXA9 methylation is not associated with survival in Brazilian patients with lung adenocarcinoma. Clin Epigenetics. 17(1): 25. https://doi.org/10.1186/s13148-025-01831-1 PMID: 39962529
  68. Welch O, Hefteh N, Sheikh M, La Caze A, Parat MO (2025). Effects of opioids on tumour growth and metastasis in animal models: a systematic review. Br J Anaesth. 134(6): 1784-1793. https://doi.org/10.1016/j.bja.2025.02.030 PMID: 40140289
  69. Werr L, Bartenhagen C, Rosswog C, Cartolano M, Voegele C, Sexton-Oates A, et al. (2025). TERT Expression and Clinical Outcome in Pulmonary Carcinoids. J Clin Oncol. 43(2): 214-225. https://doi.org/10.1200/JCO.23.02708 PMID: 39348606
  70. Winter TD, Jahagirdar O, Renal Cancer Genetics C, Johansson M, Brennan P, Machiela MJ, et al. (2025). Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes. Int J Epidemiol. 54(6): dyaf177. https://doi.org/10.1093/ije/dyaf177 PMID: 41170685
  71. Yadegar A, Dalvand S, Sharafkhah M, Sepanlou SG, Poustchi H, Roshandel G, et al. (2025). Association between prediagnostic risk factors and survival after colorectal cancer diagnosis in Golesten cohort study. Sci Rep. 15(1): 17621. https://doi.org/10.1038/s41598-025-02674-9 PMID: 40399474
  72. Yarmolinsky J, Lee MA, Lau E, Moratalla-Navarro F, Vincent EE, Li-Gao R, et al. (2025). Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djaf137 PMID: 40511612
  73. Young CD, Katki HA, Cheung LC, Rivera MP, Robbins HA, Aldrich MC, et al. (2025). Individual- and Group-Level Disparities Between Racial and Ethnic Groups in Lung Cancer Screening Eligibility Criteria. JAMA Netw Open. 8(3): e252172. https://doi.org/10.1001/jamanetworkopen.2025.2172 PMID: 40146107
  74. Zeng Y, Luo CL, Lin GW, Li F, Bai X, Ko JM, et al. (2025). Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma. J Clin Invest. 135(1). https://doi.org/10.1172/JCI182768 PMID: 39744943
  75. Alcala N, Voegele C, Mangiante L, Sexton-Oates A, Clevers H, Fernandez-Cuesta L, et al. (2024). Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms. Gigascience. 13: 13. https://doi.org/10.1093/gigascience/giae008 PMID: 38451475
  76. Ambriz-Barrera F, Rojas-Jimenez E, Diaz-Velasquez CE, De-La-Cruz-Montoya AH, Martinez-Gregorio H, Ruiz-De-La-Cruz M, et al. (2024). Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis. PLoS One. 19(9): e0308176. https://doi.org/10.1371/journal.pone.0308176 PMID: 39264897
  77. Bakhshimoghaddam F, Baez D, Dolatkhah N, Sheikh M, Poustchi H, Hekmatdoost A, et al. (2024). Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies. BMC Nutr. 10(1): 153. https://doi.org/10.1186/s40795-024-00961-8 PMID: 39609906
  78. Beigrezaei S, Dianati M, Salehi-Abargouei A, Fararouei M, Akbari-Beni A, Brinkman M, et al. (2024). The association between animal protein, plant protein, and their substitution with bladder cancer risk: a pooled analysis of 10 cohort studies. Eur J Nutr. 64(1): 55. https://doi.org/10.1007/s00394-024-03551-3 PMID: 39718625
  79. Borgmastars E, Jacobson S, Simm M, Johansson M, Billing O, Lundin C, et al. (2024). Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank. J Gastrointest Oncol. 15(2): 755-767. https://doi.org/10.21037/jgo-23-930 PMID: 38756646
  80. Borgmastars E, Ulfenborg B, Johansson M, Jonsson P, Billing O, Franklin O, et al. (2024). Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study. Transl Oncol. 48: 102059. https://doi.org/10.1016/j.tranon.2024.102059 PMID: 39018772
  81. Botteri E, Peveri G, Berstad P, Bagnardi V, Hoff G, Heath AK, et al. (2024). Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 39(2): 147-159. https://doi.org/10.1007/s10654-023-01059-4 PMID: 38180593
  82. Bouras E, Gill D, Zuber V, Murphy N, Dimou N, Aleksandrova K, et al. (2024). Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysis. Int J Epidemiol. 53(3). https://doi.org/10.1093/ije/dyae067 PMID: 38725300
  83. Bull CJ, Hazelwood E, Legge DN, Corbin LJ, Richardson TG, Lee M, et al. (2024). Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes. EBioMedicine. 100: 104977. https://doi.org/10.1016/j.ebiom.2024.104977 PMID: 38290287
  84. Caramenti L, Gradowska PL, Morina D, Byrnes G, Cardis E, Hauptmann M (2024). Finite-Sample Bias of the Linear Excess Relative Risk in Cohort Studies of Computed Tomography-Related Radiation Exposure and Cancer. Radiat Res. 201(3): 206-214. https://doi.org/10.1667/RADE-23-00187.1 PMID: 38323646
  85. Chavanel B, Virard F, Cahais V, Renard C, Sirand C, Smits KM, et al. (2024). Genome-scale mutational signature analysis in archived fixed tissues. Mutat Res Rev Mutat Res. 794: 108512. https://doi.org/10.1016/j.mrrev.2024.108512 PMID: 39216514
  86. Chen T, Pham G, Fox L, Adler N, Wang X, Zhang J, et al. (2024). Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices. EBioMedicine. 110: 105441. https://doi.org/10.1016/j.ebiom.2024.105441 PMID: 39520911
  87. Cheng TS, Noor U, Watts E, Pollak M, Wang Y, McKay J, et al. (2024). Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition. BMC Cancer. 24(1): 676. https://doi.org/10.1186/s12885-023-11425-w PMID: 38831273
  88. Cornish N, Haycock P, Brenner H, Figueiredo JC, Galesloot TE, Grant RC, et al. (2024). Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis. Int J Epidemiol. 53(1): 11. https://doi.org/10.1093/ije/dyad170 PMID: 38124529
  89. Cortez Cardoso Penha R, Sexton Oates A, Senkin S, Park HA, Atkins J, Holcatova I, et al. (2024). Understanding the biological processes of kidney carcinogenesis: an integrative multi-omics approach. Mol Syst Biol. 20(12): 1282-1302. https://doi.org/10.1038/s44320-024-00072-3 PMID: 39592856
  90. Cruz-Romero SD, Gonzalez S, Juez JY, Becerra DS, Baldion AM, Hakim JA, et al. (2024). TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Adv Ther. 41(2): 792-805. https://doi.org/10.1007/s12325-023-02756-y PMID: 38170436
  91. Desai TA, Hedman AK, Dimitriou M, Koprulu M, Figiel S, Yin W, et al. (2024). Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics. EBioMedicine. 105: 105168. https://doi.org/10.1016/j.ebiom.2024.105168 PMID: 38878676
  92. Du M, Xin J, Zheng R, Yuan Q, Wang Z, Liu H, et al. (2024). CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility. Cancer Res. 84(4): 616-625. https://doi.org/10.1158/0008-5472.CAN-23-0900 PMID: 38117513
  93. Dunlop KLA, Singh N, Robbins HA, Zahed H, Johansson M, Rankin NM, et al. (2024). Implementation considerations for risk-tailored cancer screening in the population: A scoping review. Prev Med. 181: 107897. https://doi.org/10.1016/j.ypmed.2024.107897 PMID: 38378124
  94. Engels EA, Shiels MS, Barnabas RV, Bohlius J, Brennan P, Castilho J, et al. (2024). State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI. Int J Cancer. 154(4): 596-606. https://doi.org/10.1002/ijc.34727 PMID: 37715370
  95. Etemadi A, Poustchi H, Chang CM, Calafat AM, Blount BC, Bhandari D, et al. (2024). Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer. J Natl Cancer Inst. 116(3): 379-388. https://doi.org/10.1093/jnci/djad218 PMID: 37856326
  96. Feng X, Goodley P, Alcala K, Guida F, Kaaks R, Vermeulen R, et al. (2024). Evaluation of risk prediction models to select lung cancer screening participants in Europe: a prospective cohort consortium analysis. Lancet Digit Health. 6(9): e614-e624. https://doi.org/10.1016/S2589-7500(24)00123-7 PMID: 39179310
  97. Feng X, Robbins HA, Mukeriya A, Foretova L, Holcatova I, Janout V, et al. (2024). Prognostic value of circulating proteins at diagnosis among patients with lung cancer: a comprehensive analysis by smoking status. Transl Lung Cancer Res. 13(9): 2326-2339. https://doi.org/10.21037/tlcr-24-242 PMID: 39430322
  98. Feng X, Zahed H, Onwuka J, Callister MEJ, Johansson M, Etzioni R, et al. (2024). Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis. JAMA. 331(22): 1910-1917. https://doi.org/10.1001/jama.2024.5814 PMID: 38583868
  99. Goodley P, Balata H, Robbins HA, Booton R, Sperrin M, Crosbie PAJ (2024). Six-year performance of risk-based selection for lung cancer screening in the Manchester Lung Health Check cohort. BMJ Oncol. 3(1): e000560. https://doi.org/10.1136/bmjonc-2024-000560 PMID: 40046247
  100. Gorman BR, Ji SG, Francis M, Sendamarai AK, Shi Y, Devineni P, et al. (2024). Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk. Nat Commun. 15(1): 8629. https://doi.org/10.1038/s41467-024-52129-4 PMID: 39366959
  101. Grassmann F, Malarstig A, Dahl L, Bendes A, Dale M, Thomas CE, et al. (2024). The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk. Br J Cancer. 130(4): 620-627. https://doi.org/10.1038/s41416-023-02541-2 PMID: 38135714
  102. Gustafsson S, Lampa E, Jensevik Eriksson K, Butterworth AS, Elmstahl S, Engstrom G, et al. (2024). Markers of imminent myocardial infarction. Nat Cardiovasc Res. 3(2): 130-139. https://doi.org/10.1038/s44161-024-00422-2 PMID: 39196201
  103. Inoue-Choi M, Freedman ND, Etemadi A, Hashemian M, Brennan P, Roshandel G, et al. (2024). One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study. Int J Cancer. 155(11): 1944-1957. https://doi.org/10.1002/ijc.35115 PMID: 39109892
  104. Johansson M, Robbins HA (2024). Harnessing population-wide health data to predict cancer risk. Lancet Digit Health. 6(6): e377-e378. https://doi.org/10.1016/S2589-7500(24)00093-1 PMID: 38789137
  105. Kearney LE, Belancourt P, Katki HA, Tanner NT, Wiener RS, Robbins HA, et al. (2024). The Development and Performance of Alternative Criteria for Lung Cancer Screening. Ann Intern Med. 177(9): 1222-1232. https://doi.org/10.7326/M23-3250 PMID: 39159457
  106. Koca D, Abedi-Ardekani B, LeMaoult J, Guyon L (2024). Peritumoral tissue (PTT): increasing need for naming convention. Br J Cancer. 131(7): 1111-1115. https://doi.org/10.1038/s41416-024-02828-y PMID: 39223304
  107. Koumarianou A, Filosso PL, Bodei L, Castano JP, Fernandez-Cuesta L, Deroose CM, et al. (2024). Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force. J Neuroendocrinol. 36(8): e13412. https://doi.org/10.1111/jne.13412 PMID: 38754956
  108. Koyanagi YN, Nakatochi M, Namba S, Oze I, Charvat H, Narita A, et al. (2024). Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. Sci Adv. 10(4): eade2780. https://doi.org/10.1126/sciadv.ade2780 PMID: 38277453
  109. Kusters JMA, Diergaarde B, Ness A, Schim van der Loeff MF, Heijne JCM, Schroeder L, et al. (2024). Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex. Int J Cancer. 154(2): 389-402. https://doi.org/10.1002/ijc.34710 PMID: 37694289
  110. Lam S, Bai C, Baldwin DR, Chen Y, Connolly C, de Koning H, et al. (2024). Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer. J Thorac Oncol. 19(1): 36-51. https://doi.org/10.1016/j.jtho.2023.07.019 PMID: 37487906
  111. Li Y, Xiao X, Li J, Han Y, Cheng C, Fernandes GF, et al. (2024). Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies. Cancer Epidemiol Biomarkers Prev. 33(3): 389-399. https://doi.org/10.1158/1055-9965.EPI-23-0613 PMID: 38180474
  112. Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, et al. (2024). Latin American Consensus on the Treatment of Head and Neck Cancer. JCO Glob Oncol. 10: e2300343. https://doi.org/10.1200/GO.23.00343 PMID: 38603656
  113. Moen CA, Falkenthal TE, Thorkelsen TK, Hopland A, Rio OE, Honore A, et al. (2024). Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years. Eur Urol Oncol. 7(4): 778-785. https://doi.org/10.1016/j.euo.2023.10.013 PMID: 37949729
  114. Moirangthem R, Hosseini B, Patil A, George GS, Manjrekar A, Doibale P, et al. (2024). Occupations and the risk of buccal mucosa cancer in Indian men: A multi-centre case-control study. Cancer Epidemiol. 92: 102644. https://doi.org/10.1016/j.canep.2024.102644 PMID: 39153274
  115. Morales-Berstein F, Biessy C, Viallon V, Goncalves-Soares A, Casagrande C, Hemon B, et al. (2024). Ultra-processed foods, adiposity and risk of head and neck cancer and oesophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study: a mediation analysis. Eur J Nutr. 63(2): 377-396. https://doi.org/10.1007/s00394-023-03270-1 PMID: 37989797
  116. Nalini M, Poustchi H, Bhandari D, Chang CM, Blount BC, Wang L, et al. (2024). Volatile organic compounds and mortality from ischemic heart disease: A case-cohort study. Am J Prev Cardiol. 19: 100700. https://doi.org/10.1016/j.ajpc.2024.100700 PMID: 39100747
  117. Nemati S, Dardashti AR, Mohebbi E, Kamangar F, Malekzadeh R, Zendehdel K, et al. (2024). Potential impact of controlling opium use prevalence on future cancer incidence in Iran. EClinicalMedicine. 73: 102650. https://doi.org/10.1016/j.eclinm.2024.102650 PMID: 38881571
  118. Nemati S, Islami F, Kamangar F, Poustchi H, Roshandel G, Shakeri R, et al. (2024). Improvement of esophageal cancer survival in Northeast Iran: A two-decade journey in a high-risk, low- resource region. PLoS One. 19(9): e0310842. https://doi.org/10.1371/journal.pone.0310842 PMID: 39321196
  119. Ni Z, Kundu P, McKean DF, Wheeler W, Albanes D, Andreotti G, et al. (2024). Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 33(9): 1229-1239. https://doi.org/10.1158/1055-9965.EPI-24-0096 PMID: 38869494
  120. Onwuka JU, Guida F, Langdon R, Johansson M, Severi G, Milne RL, et al. (2024). Blood-based DNA methylation markers for lung cancer prediction. BMJ Oncol. 3(1): e000334. https://doi.org/10.1136/bmjonc-2024-000334 PMID: 39886123
  121. Onwuka JU, Wuraola FO, Owoade IA, Ogunyemi YF, Di Bernardo M, Dare AJ, et al. (2024). Delays in Presentation, Diagnosis, and Treatment Among Patients With GI Cancer in Southwest Nigeria. JCO Glob Oncol. 10: e2400060. https://doi.org/10.1200/GO.24.00060 PMID: 39418630
  122. Orive D, Echepare M, Bernasconi-Bisio F, Sanmamed MF, Pineda-Lucena A, de la Calle-Arroyo C, et al. (2024). Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment. Arch Bronconeumol. 60 Suppl 2: S67-S76. https://doi.org/10.1016/j.arbres.2024.07.007 PMID: 39079848
  123. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. (2024). The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 4(3): 100500. https://doi.org/10.1016/j.xgen.2024.100500 PMID: 38325367
  124. Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, et al. (2024). Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 56(5): 809-818. https://doi.org/10.1038/s41588-024-01725-7 PMID: 38671320
  125. Rabien A, Rong D, Rabenhorst S, Schlomm T, Labonte F, Hofbauer S, et al. (2024). Diagnostic performance of Uromonitor and TERTpm ddPCR urine tests for the non-invasive detection of bladder cancer. Sci Rep. 14(1): 30617. https://doi.org/10.1038/s41598-024-83976-2 PMID: 39715826
  126. Reddy SSP, Francis DL, Kulkarni V, Chopra SS (2024). Letter to editor on ‘isolation and characterization of human Wharton’s jelly mesenchymal stem cell-derived extracellular vesicles’. J Cell Mol Med. 28(20): e70168. https://doi.org/10.1111/jcmm.70168 PMID: 39438269
  127. Robbins HA (2024). Multicancer Early Detection Tests – Keeping a High Bar for Evidence of Benefit. N Engl J Med. 391(4): 292-294. https://doi.org/10.1056/NEJMp2400297 PMID: 39037048
  128. Robbins HA, Feng X, Etzioni R (2024). Cancer Stage vs Mortality End Points in Randomized Clinical Trials of Cancer Screening. JAMA. 332(14): 2. https://doi.org/10.1001/jama.2024.16365 PMID: 39264595
  129. Ruiz-De La Cruz M, Martinez-Gregorio H, Estela Diaz-Velasquez C, Ambriz-Barrera F, Resendiz-Flores NG, Gitler-Weingarten R, et al. (2024). Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria. NPJ Precis Oncol. 8(1): 136. https://doi.org/10.1038/s41698-024-00611-z PMID: 38898118
  130. Senkin S, Moody S, Diaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. (2024). Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 629(8013): 910-918. https://doi.org/10.1038/s41586-024-07368-2 PMID: 38693263
  131. Smith CDL, McMahon AD, Lyall DM, Goulart M, Inman GJ, Ross A, et al. (2024). Development and external validation of a head and neck cancer risk prediction model. Head Neck. 46(9): 2261-2273. https://doi.org/10.1002/hed.27834 PMID: 38850089
  132. Smith-Byrne K, Hedman A, Dimitriou M, Desai T, Sokolov AV, Schioth HB, et al. (2024). Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers. Nat Commun. 15(1): 3621. https://doi.org/10.1038/s41467-024-46834-3 PMID: 38684708
  133. Thakral A, Lee JJ, Hou T, Hueniken K, Dudding T, Gormley M, et al. (2024). Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nat Commun. 15(1): 7835. https://doi.org/10.1038/s41467-024-51679-x PMID: 39244563
  134. Viallon V, Freisling H, Matta K, Nannsen AO, Dahm CC, Tjonneland A, et al. (2024). On the use of the healthy lifestyle index to investigate specific disease outcomes. Sci Rep. 14(1): 16330. https://doi.org/10.1038/s41598-024-66772-w PMID: 39009699
  135. Wang X, Zhang Z, Ding Y, Chen T, Mucci L, Albanes D, et al. (2024). Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification. Genome Med. 16(1): 22. https://doi.org/10.1186/s13073-024-01298-4 PMID: 38317189
  136. Watts EL, Gonzales TI, Strain T, Saint-Maurice PF, Bishop DT, Chanock SJ, et al. (2024). Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study. Br J Cancer. 130(1): 114-124. https://doi.org/10.1038/s41416-023-02489-3 PMID: 38057395
  137. Whitham L, Sheikh M, Hollmann MW, Parat MO (2024). The Comparative Effect of Morphine on Proliferation of Cancer Cell Lines Originating from Different Organs: An In Vitro Study. Pharmaceuticals (Basel). 17(12). https://doi.org/10.3390/ph17121656 PMID: 39770497
  138. Xu W, Gaborieau V, Niman SM, Mukeria A, Liu X, Maremanda KP, et al. (2024). Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes. J Clin Oncol. 42(22): 2691-2701. https://doi.org/10.1200/JCO.23.00699 PMID: 38701382
  139. Yang JJ, Wen W, Zahed H, Zheng W, Lan Q, Abe SK, et al. (2024). Lung Cancer Risk Prediction Models for Asian Ever-Smokers. J Thorac Oncol. 19(3): 451-464. https://doi.org/10.1016/j.jtho.2023.11.002 PMID: 37944700
  140. Yano Y, Abnet CC, Roshandel G, Graf A, Poustchi H, Khoshnia M, et al. (2024). Dental health and lung cancer risk in the Golestan Cohort Study. BMC Cancer. 24(1): 74. https://doi.org/10.1186/s12885-024-11850-5 PMID: 38218793
  141. Yarmolinsky J, Robinson JW, Mariosa D, Karhunen V, Huang J, Dimou N, et al. (2024). Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine. 100: 104991. https://doi.org/10.1016/j.ebiom.2024.104991 PMID: 38301482
  142. Yazdanpanah MH, Sharafkhah M, Poustchi H, Etemadi A, Sheikh M, Kamangar F, et al. (2024). Mineral Intake and Cardiovascular Disease, Cancer, and All-Cause Mortality: Findings from the Golestan Cohort Study. Nutrients. 16(3): 23. https://doi.org/10.3390/nu16030344 PMID: 38337629
  143. Zahed H, Feng X, Sheikh M, Bray F, Ferlay J, Ginsburg O, et al. (2024). Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study. Int J Cancer. 154(1): 28-40. https://doi.org/10.1002/ijc.34671 PMID: 37615573
  144. Zhang Y, Khil J, Feng X, Ugai T, Ogino S, Giovannucci E (2024). Risk of colorectal cancer and adenoma after an appendectomy: results from three large prospective cohort studies and meta-analysis. Cancer Causes Control. 35(11): 1457-1466. https://doi.org/10.1007/s10552-024-01901-4 PMID: 39066935
  145. Zhao X, Yang M, Fan J, Wang M, Wang Y, Qin N, et al. (2024). Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls. Cancer. 130(6): 913-926. https://doi.org/10.1002/cncr.35130 PMID: 38055287
  146. Alcala K, Poustchi H, Viallon V, Islami F, Pourshams A, Sadjadi A, et al. (2023). Incident cancers attributable to using opium and smoking cigarettes in the Golestan cohort study. EClinicalMedicine. 64: 102229. https://doi.org/10.1016/j.eclinm.2023.102229 PMID: 37781157
  147. Alcala K, Zahed H, Cortez Cardoso Penha R, Alcala N, Robbins HA, Smith-Byrne K, et al. (2023). Kidney Function and Risk of Renal Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 32(11): 1644-1650. https://doi.org/10.1158/1055-9965.Epi-23-0558 PMID: 37668600
  148. Alcala N, Fernandez-Cuesta LA (2023). Lifting the curtain on molecular differences between malignant pleural mesotheliomas. Nat Genet. 55(4): 540-541. https://doi.org/10.1038/s41588-023-01322-0 PMID: 36928604
  149. Arboleda LPA, de Carvalho GB, Santos-Silva AR, Fernandes GA, Vartanian JG, Conway DI, et al. (2023). Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide. Cancers (Basel). 15(17). https://doi.org/10.3390/cancers15174405 PMID: 37686681
  150. Arboleda LPA, Neves AB, Kohler HF, Vartanian JG, Candelaria LM, Borges MF, et al. (2023). Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022. Cancer Rep (Hoboken). 6(8): e1837. https://doi.org/10.1002/cnr2.1837 PMID: 37288471
  151. Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. (2023). Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 37(10): 2142-2142. https://doi.org/10.1038/s41375-023-01978-x PMID: 37666943
  152. Blazquez-Encinas R, Garcia-Vioque V, Caro-Cuenca T, Moreno-Montilla MT, Mangili F, Alors-Perez E, et al. (2023). Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery. J Transl Med. 21(1): 879. https://doi.org/10.1186/s12967-023-04754-8 PMID: 38049848
  153. Budhathoki S, Diergaarde B, Liu G, Olshan A, Ness A, Waterboer T, et al. (2023). A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. Int J Cancer. 152(10): 2069-2080. https://doi.org/10.1002/ijc.34444 PMID: 36694401
  154. Callister MEJ, Crosbie EJ, Crosbie PAJ, Robbins HA (2023). Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage. Br J Cancer. 129(8): 1209-1211. https://doi.org/10.1038/s41416-023-02434-4 PMID: 37726480
  155. Casolino R, Johns AL, Courtot M, Lawlor RT, De Lorenzo F, Horgan D, et al. (2023). Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission. Lancet Oncol. 24(2): 123-125. https://doi.org/10.1016/S1470-2045(23)00007-4 PMID: 36725142
  156. Cheng C, Hong W, Li Y, Xiao X, McKay J, Han Y, et al. (2023). Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. J Thorac Oncol. 18(8): 1003-1016. https://doi.org/10.1016/j.jtho.2023.05.001 PMID: 37150255
  157. Clasen JL, Mabunda R, Heath AK, Kaaks R, Katzke V, Schulze MB, et al. (2023). Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(14): 15588-15600. https://doi.org/10.1002/cam4.6207 PMID: 37269199
  158. Cortez Cardoso Penha R, Smith-Byrne K, Atkins JR, Haycock PC, Kar S, Codd V, et al. (2023). Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome. Elife. 12. https://doi.org/10.7554/eLife.83118 PMID: 37079368
  159. Dayton TL, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, et al. (2023). Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites. Cancer Cell. 41(12): 2083-2099 e2089. https://doi.org/10.1016/j.ccell.2023.11.007 PMID: 38086335
  160. Diaz-Gay M, Vangara R, Barnes M, Wang X, Islam SMA, Vermes I, et al. (2023). Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. Bioinformatics. 39(12): 5. https://doi.org/10.1093/bioinformatics/btad756 PMID: 38096571
  161. Diaz-Velasquez CE, Gitler R, Antoniano A, Kershenovich Sefchovich R, De La Cruz-Montoya AH, Martinez-Gregorio H, et al. (2023). Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. Front Genet. 14: 1094260. https://doi.org/10.3389/fgene.2023.1094260 PMID: 36845387
  162. D’Souza G, Tewari SR, Troy T, Waterboer T, Struijk L, Castillo R, et al. (2023). Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study. Cancer. 129(15): 2373-2384. https://doi.org/10.1002/cncr.34783 PMID: 37032449
  163. Dumontet C, Demangel D, Galia P, Karlin L, Roche L, Fauvernier M, et al. (2023). Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myelome study. Am J Hematol. 98(2): 264-271. https://doi.org/10.1002/ajh.26785 PMID: 36588407
  164. Fares AF, Li Y, Jiang M, Brown MC, Lam ACL, Aggarwal R, et al. (2023). Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. Lancet Public Health. 8(9): E691-E700. https://doi.org/10.1016/S2468-2667(23)00131-7 PMID: 37633678
  165. Feng X, Muller DC, Zahed H, Alcala K, Guida F, Smith-Byrne K, et al. (2023). Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis. EBioMedicine. 92: 104623. https://doi.org/10.1016/j.ebiom.2023.104623 PMID: 37236058
  166. Feng X, Wu WY, Onwuka JU, Haider Z, Alcala K, Smith-Byrne K, et al. (2023). Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools. J Natl Cancer Inst. 115(9): 1050-1059. https://doi.org/10.1093/jnci/djad071 PMID: 37260165
  167. Feng X, Zhang Y, Vaselkiv JB, Li R, Nguyen PL, Penney KL, et al. (2023). Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsy. Br J Cancer. 129(12): 1988-2002. https://doi.org/10.1038/s41416-023-02472-y PMID: 37898724
  168. Fernandez-Cuesta L, Sexton-Oates A, Bayat L, Foll M, Lau SCM, Leal T (2023). Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms. Am Soc Clin Oncol Educ Book. 43: e390794. https://doi.org/10.1200/EDBK_390794 PMID: 37229617
  169. Garcia-Pardo M, Chang A, Schmid S, Dong M, Brown MC, Christiani D, et al. (2023). Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. J Thorac Oncol. 18(3): 313-323. https://doi.org/10.1016/j.jtho.2022.10.020 PMID: 36396063
  170. Goyal N, Hennessy M, Lehman E, Lin W, Agudo A, Ahrens W, et al. (2023). Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium. Oral Dis. 29(4): 1565-1578. https://doi.org/10.1111/odi.14196 PMID: 35322907
  171. Hadji M, Marzban M, Rashidian H, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2023). Opium use and risk of colorectal cancer: a multi-center case-referent study in Iran. Acta Oncol. 62(12): 1661-1668. https://doi.org/10.1080/0284186X.2023.2276326 PMID: 37934078
  172. Haycock PC, Borges MC, Burrows K, Lemaitre RN, Harrison S, Burgess S, et al. (2023). Design and quality control of large-scale two-sample Mendelian randomization studies. Int J Epidemiol. 52(5): 1498-1521. https://doi.org/10.1093/ije/dyad018 PMID: 38587501
  173. Hosseini E, Mokhtari Z, Poustchi H, Khoshnia M, Dawsey SM, Boffetta P, et al. (2023). Dietary Advanced Glycation End Products and Risk of Overall and Cause-Specific Mortality: Results from the Golestan Cohort Study. Int J Environ Res Public Health. 20(5): 3788. https://doi.org/10.3390/ijerph20053788 PMID: 36900799
  174. Khan SM, Das T, Chakraborty S, Choudhury A, Karim HF, Mostofa MA, et al. (2023). A transcriptome study of p53-pathway related prognostic gene signature set in bladder cancer. Heliyon. 9(10): e21058. https://doi.org/10.1016/j.heliyon.2023.e21058 PMID: 37876438
  175. Khodayari Moez E, Warkentin MT, Brhane Y, Lam S, Field JK, Liu G, et al. (2023). Circulating proteome for pulmonary nodule malignancy. J Natl Cancer Inst. 115(9): 1060-1070. https://doi.org/10.1093/jnci/djad122 PMID: 37369027
  176. King SD, Veliginti S, Brouwers M, Ren Z, Zheng W, Setiawan VW, et al. (2023). Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Cancer Epidemiol Biomarkers Prev. 32(9): 1265-1269. https://doi.org/10.1158/1055-9965.EPI-23-0453 PMID: 37351909
  177. Kolijn PM, Späth F, Khouja M, Hengeveld PJ, van der Straten L, Darzentas N, et al. (2023). Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis. Blood. 142(16): 1399-1403. https://doi.org/10.1182/blood.2023019609 PMID: 37523714
  178. Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, et al. (2023). Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Eur Urol. 84(1): 127-137. https://doi.org/10.1016/j.eururo.2023.04.020 PMID: 37210288
  179. Landy R, Gomez I, Caverly TJ, Kawamoto K, Rivera MP, Robbins HA, et al. (2023). Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility. Jama Network Open. 6(9): e2331155. https://doi.org/10.1001/jamanetworkopen.2023.31155 PMID: 37721755
  180. Landy R, Wang VL, Baldwin DR, Pinsky PF, Cheung LC, Castle PE, et al. (2023). Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals. JAMA Netw Open. 6(3): e233273. https://doi.org/10.1001/jamanetworkopen.2023.3273 PMID: 36929398
  181. Lawrence P, Chabane M, Abrouk L, Thiesson A, Berthe D, Diarra AB, et al. (2023). First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali. Diagnostics (Basel). 13(3): 375. https://doi.org/10.3390/diagnostics13030375 PMID: 36766478
  182. Lee R, Robbins HA (2023). PATHFINDER: another step on the uncharted path to multicancer screening. Lancet. 402(10409): 1213-1215. https://doi.org/10.1016/S0140-6736(23)02050-0 PMID: 37805199
  183. Leyden GM, Greenwood MP, Gaborieau V, Han Y, Amos CI, Brennan P, et al. (2023). Disentangling the aetiological pathways between body mass index and site-specific cancer risk using tissue-partitioned Mendelian randomisation. Br J Cancer. 128(4): 618-625. https://doi.org/10.1038/s41416-022-02060-6 PMID: 36434155
  184. Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, et al. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5): 846-854. https://doi.org/10.1136/gutjnl-2022-328233 PMID: 36241389
  185. Lindstrom S, Wang L, Feng H, Majumdar A, Huo S, Macdonald J, et al. (2023). Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. J Natl Cancer Inst. 115(6): 712-732. https://doi.org/10.1093/jnci/djad043 PMID: 36929942
  186. Loding S, Andersson U, Kaaks R, Schulze MB, Pala V, Urbarova I, et al. (2023). Altered plasma metabolite levels can be detected years before a glioma diagnosis. JCI Insight. 8(19): e171225. https://doi.org/10.1172/jci.insight.171225 PMID: 37651185
  187. Lung Cancer Cohort C (2023). The blood proteome of imminent lung cancer diagnosis. Nat Commun. 14(1): 3042. https://doi.org/10.1038/s41467-023-37979-8 PMID: 37264016
  188. Luyapan J, Bossé Y, Li Z, Xiao X, Rosenberger A, Hung RJ, et al. (2023). Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk. Hum Mol Genet. 32(18): 2842-2855. https://doi.org/10.1093/hmg/ddad095 PMID: 37471639
  189. M Filho A, Turner MC, Warnakulasuriya S, Richardson DB, Hosseini B, Kamangar F, et al. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis. Eur J Epidemiol. 38(4): 373-389. https://doi.org/10.1007/s10654-023-00969-7 PMID: 36773182
  190. Malarstig A, Grassmann F, Dahl L, Dimitriou M, McLeod D, Gabrielson M, et al. (2023). Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. Nat Commun. 14(1): 7680. https://doi.org/10.1038/s41467-023-43485-8 PMID: 37996402
  191. Mangiante L, Alcala N, Sexton-Oates A, Di Genova A, Gonzalez-Perez A, Khandekar A, et al. (2023). Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nat Genet. 55(4): 607-618. https://doi.org/10.1038/s41588-023-01321-1 PMID: 36928603
  192. Midttun O, Ulvik A, Meyer K, Zahed H, Giles GG, Manjer J, et al. (2023). A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium. Sci Rep. 13(1): 1011. https://doi.org/10.1038/s41598-023-28135-9 PMID: 36653422
  193. Nalini M, Poustchi H, Roshandel G, Kamangar F, Khoshnia M, Gharavi A, et al. (2023). Association Between Incident Type 2 Diabetes and Opium Use: Mediation by Body Mass and Adiposity. Am J Epidemiol. 192(12): 2050-2062. https://doi.org/10.1093/aje/kwad166 PMID: 37552966
  194. Namaki M, Hashemian M, Arj A, Poustchi H, Roshandel G, Loghman AH, et al. (2023). Diet Quality and Subsequent Incidence of Upper Gastrointestinal Cancers: Results from the Golestan Cohort Study. Arch Iran Med. 26(9): 489-498. https://doi.org/10.34172/aim.2023.74 PMID: 38310404
  195. Nemati S, Mohebbi E, Toorang F, Hadji M, Hosseini B, Saeedi E, et al. (2023). Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020. Int J Cancer. 153(10): 1758-1765. https://doi.org/10.1002/ijc.34659 PMID: 37548110
  196. Nemati S, Naji P, Abdi S, Lotfi F, Saeedi E, Mehravar SA, et al. (2023). National and Regional Fraction of Cancer Incidence and Death Attributable to Current Tobacco and Water-Pipe Smoking in the Eastern Mediterranean Countries in 2020. Nicotine Tob Res. 25(1): 12-18. https://doi.org/10.1093/ntr/ntac179 PMID: 35895382
  197. Nemati S, Saeedi E, Lotfi F, Nahvijou A, Pirnejad H, Cheraghi M, et al. (2023). Regional disparities in cancer survival in Iran: Insight from a National Surveillance of Cancer Survival in Iran (IRANCANSURV). Cancer Epidemiol. 85: 102378. https://doi.org/10.1016/j.canep.2023.102378 PMID: 37229955
  198. Nost TH, Skogholt AH, Urbarova I, Mjelle R, Paulsen EE, Donnem T, et al. (2023). Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer. Mol Oncol. 17(2): 312-327. https://doi.org/10.1002/1878-0261.13336 PMID: 36337027
  199. Papadimitriou N, Bull CJ, Jenab M, Hughes DJ, Bell JA, Sanderson E, et al. (2023). Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study. BMC Med. 21(1): 5. https://doi.org/10.1186/s12916-022-02702-9 PMID: 36600297
  200. Perim Galvao De Podesta O, Salaroli LB, Cattafesta M, Peres SV, De Podesta JRV, von Zeidler SLV, et al. (2023). Changes in Body Mass Index Are Associated with Squamous Cell Carcinomas of Oral Cavity, Oropharynx and Larynx: A Case-Control Study in Brazil. Nutr Cancer. 75(2): 599-609. https://doi.org/10.1080/01635581.2022.2143535 PMID: 36426640
  201. Rashidian H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, Marzban M, Mohebbi E, et al. (2023). Opium use and risk of lung cancer: A multicenter case-control study in Iran. Int J Cancer. 152(2): 203-213. https://doi.org/10.1002/ijc.34244 PMID: 36043555
  202. Robbins HA, Alcala K, Moez EK, Guida F, Thomas S, Zahed H, et al. (2023). Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. Ann Epidemiol. 77: 1-12. https://doi.org/10.1016/j.annepidem.2022.10.014 PMID: 36404465
  203. Rogers M, Gill D, Ahlqvist E, Robinson T, Mariosa D, Johansson M, et al. (2023). Genetically proxied impaired GIPR signaling and risk of 6 cancers. iScience. 26(6): 106848. https://doi.org/10.1016/j.isci.2023.106848 PMID: 37250804
  204. Sheikh M, Brennan P, Mariosa D, Robbins HA (2023). Opioid medications: an emerging cancer risk factor? Br J Anaesth. 130(3): e401-e403. https://doi.org/10.1016/j.bja.2022.12.007 PMID: 36682937
  205. Sheikh M, Mukeriya A, Zahed H, Feng X, Robbins HA, Shangina O, et al. (2023). Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study. J Clin Oncol. 41(15): 2747-2755. https://doi.org/10.1200/JCO.22.02472 PMID: 36989465
  206. Sheikh M, Roshandel G, McCormack V, Malekzadeh R (2023). Current Status and Future Prospects for Esophageal Cancer. Cancers (Basel). 15(3). https://doi.org/10.3390/cancers15030765 PMID: 36765722
  207. Sheikh M, Virani S, Robbins HA, Foretova L, Holcatova I, Janout V, et al. (2023). Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study. Cancer Med. 12(9): 10563-10574. https://doi.org/10.1002/cam4.5791 PMID: 36952375
  208. Shi J, Shiraishi K, Choi J, Matsuo K, Chen TY, Dai J, et al. (2023). Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nat Commun. 14(1): 3043. https://doi.org/10.1038/s41467-023-38196-z PMID: 37236969
  209. Soroush A, Malekzadeh R, Roshandel G, Khoshnia M, Poustchi H, Kamangar F, et al. (2023). Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study. Int J Cancer. 152(6): 1137-1149. https://doi.org/10.1002/ijc.34313 PMID: 36214797
  210. Sugier PE, Lucotte EA, Domenighetti C, Law MH, Iles MM, Brown K, et al. (2023). Investigation of Shared Genetic Risk Factors Between Parkinson’s Disease and Cancers. Mov Disord. 38(4): 604-615. https://doi.org/10.1002/mds.29337 PMID: 36788297
  211. Takata Y, Yang JJ, Yu D, Smith-Warner SA, Blot WJ, White E, et al. (2023). Calcium Intake and Lung Cancer Risk: A Pooled Analysis of 12 Prospective Cohort Studies. J Nutr. 153(7): 2051-2060. https://doi.org/10.1016/j.tjnut.2023.03.011 PMID: 36907443
  212. Vasudev NS, Scelo G, Glennon KI, Wilson M, Letourneau L, Eveleigh R, et al. (2023). Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma. Clin Cancer Res. 29(7): 1220-1231. https://doi.org/10.1158/1078-0432.CCR-22-1936 PMID: 36815791
  213. Wu WY, Haider Z, Feng X, Heath AK, Tjonneland A, Agudo A, et al. (2023). Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts. Int J Cancer. 152(9): 2002-2010. https://doi.org/10.1002/ijc.34340 PMID: 36305647
  214. Yammine SG, Huybrechts I, Biessy C, Dossus L, Panico S, Sanchez MJ, et al. (2023). Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. BMC Cancer. 23(1): 159. https://doi.org/10.1186/s12885-023-10611-0 PMID: 36797668
  215. Zvereva M, Hosen MI, Forey N, Sheikh M, Kannengiesser C, Ba I, et al. (2023). Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-invasive Diagnosis of Urothelial Cancer. Methods Mol Biol. 2684: 213-228. https://doi.org/10.1007/978-1-0716-3291-8_13 PMID: 37410237
  216. Alcala K, Mariosa D, Smith-Byrne K, Nasrollahzadeh Nesheli D, Carreras-Torres R, Ardanaz Aicua E, et al. (2022). The relationship between blood pressure and risk of renal cell carcinoma. Int J Epidemiol. 51(4): 1317-1327. https://doi.org/10.1093/ije/dyac042 PMID: 35312764
  217. Alcala N, Rosenberg NA (2022). Mathematical constraints on F(ST): multiallelic markers in arbitrarily many populations. Philos Trans R Soc Lond B Biol Sci. 377(1852): 20200414. https://doi.org/10.1098/rstb.2020.0414 PMID: 35430885
  218. Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. (2022). Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 36(12): 2835-2844. https://doi.org/10.1038/s41375-022-01711-0 PMID: 36273105
  219. Bouras E, Karhunen V, Gill D, Huang J, Haycock PC, Gunter MJ, et al. (2022). Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 20(1): 3. https://doi.org/10.1186/s12916-021-02193-0 PMID: 35012533
  220. Bouvard V, Nethan ST, Singh D, Warnakulasuriya S, Mehrotra R, Chaturvedi AK, et al. (2022). IARC Perspective on Oral Cancer Prevention. N Engl J Med. 387(21): 1999-2005. https://doi.org/10.1056/NEJMsr2210097 PMID: 36378601
  221. Breeur M, Ferrari P, Dossus L, Jenab M, Johansson M, Rinaldi S, et al. (2022). Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 20(1): 351. https://doi.org/10.1186/s12916-022-02553-4 PMID: 36258205
  222. Brennan P, Davey-Smith G (2022). Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed. J Natl Cancer Inst. 114(3): 353-360. https://doi.org/10.1093/jnci/djab204 PMID: 34743211
  223. Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. (2022). Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 82(5): 529-542. https://doi.org/10.1016/j.eururo.2022.08.019 PMID: 36100483
  224. Byun J, Han Y, Li Y, Xia J, Long E, Choi J, et al. (2022). Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. Nat Genet. 54(8): 1167-1177. https://doi.org/10.1038/s41588-022-01115-x PMID: 35915169
  225. Cai J, Chen H, Lu M, Zhang Y, Lu B, Luo C, et al. (2022). Association between Temporal Glycemic Change and Risk of Pancreatic Cancer in Men: A Prospective Cohort Study. Cancers (Basel). 14(14): 12. https://doi.org/10.3390/cancers14143403 PMID: 35884465
  226. Claeys L, De Saeger S, Scelo G, Biessy C, Casagrande C, Nicolas G, et al. (2022). Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort. Nutrients. 14(17): 3581. https://doi.org/10.3390/nu14173581 PMID: 36079840
  227. Clasen JL, Heath AK, Van Puyvelde H, Huybrechts I, Park JY, Ferrari P, et al. (2022). Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Cancer. 151(5): 708-716. https://doi.org/10.1002/ijc.34009 PMID: 35366005
  228. Collatuzzo G, Etemadi A, Sotoudeh M, Nikmanesh A, Poustchi H, Khoshnia M, et al. (2022). Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran. Int J Cancer. 151(7): 1005-1012. https://doi.org/10.1002/ijc.34056 PMID: 35489023
  229. Di Genova A, Mangiante L, Sexton-Oates A, Voegele C, Fernandez-Cuesta L, Alcala N, et al. (2022). A molecular phenotypic map of malignant pleural mesothelioma. Gigascience. 12: 13. https://doi.org/10.1093/gigascience/giac128 PMID: 36705549
  230. Dianatinasab M, Wesselius A, Salehi-Abargouei A, Yu EYW, Fararouei M, Brinkman M, et al. (2022). Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies. Int J Cancer. 151(1): 44-55. https://doi.org/10.1002/ijc.33970 PMID: 35182086
  231. Ecke TH, Le Calvez-Kelm F, Otto T (2022). Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision. Int J Mol Sci. 23(10): 5620. https://doi.org/10.3390/ijms23105620 PMID: 35628431
  232. Emerson MA, Farquhar DR, Lenze NR, Sheth S, Mazul AL, Zanation AM, et al. (2022). Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients. Head Neck. 44(4): 823-834. https://doi.org/10.1002/hed.26977 PMID: 35044015
  233. Etemadi A, Hariri S, Hassanian-Moghaddam H, Poustchi H, Roshandel G, Shayanrad A, et al. (2022). Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan Cohort Study. Int J Drug Policy. 104: 103695. https://doi.org/10.1016/j.drugpo.2022.103695 PMID: 35472727
  234. Feng XS, Zahed H, Robbins HA (2022). Editorial Comment. J Urol. 207(2): 332. https://doi.org/10.1097/JU.0000000000002249.01 PMID: 34781695
  235. Gabriel AAG, Atkins JR, Penha RCC, Smith-Byrne K, Gaborieau V, Voegele C, et al. (2022). Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden. J Natl Cancer Inst. 114(8): 1159-1166. https://doi.org/10.1093/jnci/djac087 PMID: 35511172
  236. Galati L, Combes JD, Le Calvez-Kelm F, McKay-Chopin S, Forey N, Ratel M, et al. (2022). Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay. Microbiol Spectr. 10(2): e0148021. https://doi.org/10.1128/spectrum.01480-21 PMID: 35225653
  237. Gislon LC, Curado MP, Lopez RVM, de Oliveira JC, Vasconcelos de Podesta JR, Ventorin von Zeidler S, et al. (2022). Risk factors associated with head and neck cancer in former smokers: A Brazilian multicentric study. Cancer Epidemiol. 78: 102143. https://doi.org/10.1016/j.canep.2022.102143 PMID: 35378425
  238. Gormley M, Dudding T, Kachuri L, Burrows K, Chong AHW, Martin RM, et al. (2022). Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization. BMC Med. 20(1): 40. https://doi.org/10.1186/s12916-022-02233-3 PMID: 35094705
  239. Guida F, Kidman R, Ferlay J, Schuz J, Soerjomataram I, Kithaka B, et al. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 28(12): 2563-2572. https://doi.org/10.1038/s41591-022-02109-2 PMID: 36404355
  240. Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2022). Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. Int J Epidemiol. 51(3): 830-838. https://doi.org/10.1093/ije/dyac031 PMID: 35244716
  241. Hasanau T, Pisarev E, Kisil O, Nonoguchi N, Le Calvez-Kelm F, Zvereva M (2022). Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances. Biomedicines. 10(3). https://doi.org/10.3390/biomedicines10030728 PMID: 35327529
  242. Hejazi E, Emamat H, Sharafkhah M, Saidpour A, Poustchi H, Sepanlou S, et al. (2022). Dietary acid load and mortality from all causes, CVD and cancer: results from the Golestan Cohort Study. Br J Nutr. 128(2): 237-243. https://doi.org/10.1017/S0007114521003135 PMID: 34392847
  243. Hemissi I, Boussetta S, Dallali H, Hellal F, Durand G, Voegele C, et al. (2022). Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Mol Biol Rep. 49(2): 1233-1258. https://doi.org/10.1007/s11033-021-06951-4 PMID: 34854013
  244. Hemissi I, Boussetta S, Dallali H, Hellal F, Durand G, Voegele C, et al. (2022). Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Mol Biol Rep. 49(2): 1259. https://doi.org/10.1007/s11033-021-07052-y PMID: 34977990
  245. Hong W, Li A, Liu Y, Xiao X, Christiani DC, Hung RJ, et al. (2022). Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. Cancer Res. 82(2): 199-209. https://doi.org/10.1158/0008-5472.CAN-21-1903 PMID: 34815255
  246. Islam SMA, Diaz-Gay M, Wu Y, Barnes M, Vangara R, Bergstrom EN, et al. (2022). Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. 2(11): None. https://doi.org/10.1016/j.xgen.2022.100179 PMID: 36388765
  247. Kolijn PM, Hosnijeh FS, Spath F, Hengeveld PJ, Agathangelidis A, Saleh M, et al. (2022). High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood. 139(10): 1557-1563. https://doi.org/10.1182/blood.2021012890 PMID: 34662377
  248. Li M, Zhang L, Charvat H, Callister ME, Sasieni P, Christodoulou E, et al. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. Int J Cancer. 151(9): 1491-1501. https://doi.org/10.1002/ijc.34167 PMID: 35809038
  249. Li Y, Xiao X, Li J, Byun J, Cheng C, Bosse Y, et al. (2022). Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk. Hum Mol Genet. 31(16): 2831-2843. https://doi.org/10.1093/hmg/ddac030 PMID: 35138370
  250. Mariosa D, Smith-Byrne K, Richardson TG, Ferrari P, Gunter MJ, Papadimitriou N, et al. (2022). Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study. J Natl Cancer Inst. 114(9): 1296-1300. https://doi.org/10.1093/jnci/djac061 PMID: 35438160
  251. Masukume G, Mmbaga BT, Dzamalala CP, Mlombe YB, Finch P, Nyakunga-Maro G, et al. (2022). A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case-control studies. Br J Cancer. 127(6): 1106-1115. https://doi.org/10.1038/s41416-022-01890-8 PMID: 35768549
  252. Mc Leer A, Foll M, Brevet M, Antoine M, Novello S, Mondet J, et al. (2022). Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. Lung Cancer. 167: 98-106. https://doi.org/10.1016/j.lungcan.2022.01.008 PMID: 35183375
  253. Middleton DRS, Mmbaga BT, Menya D, Dzamalala C, Nyakunga-Maro G, Finch P, et al. (2022). Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health. 10(2): e236-e245. https://doi.org/10.1016/S2214-109X(21)00506-4 PMID: 34921758
  254. Mobuchon L, Derrien AC, Houy A, Verrier T, Pierron G, Cassoux N, et al. (2022). Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas. J Natl Cancer Inst. 114(2): 302-309. https://doi.org/10.1093/jnci/djab167 PMID: 34424336
  255. Moonen L, Mangiante L, Leunissen DJG, Lap LMV, Gabriel A, Hillen LM, et al. (2022). Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation. Int J Cancer. 150(12): 1987-1997. https://doi.org/10.1002/ijc.33939 PMID: 35076935
  256. Morrison ML, Alcala N, Rosenberg NA (2022). FSTruct: An F(ST) -based tool for measuring ancestry variation in inference of population structure. Mol Ecol Resour. 22(7): 2614-2626. https://doi.org/10.1111/1755-0998.13647 PMID: 35596736
  257. Mountzias A, Hultdin J, Hlodan J, Kroger Dahlin BI, Johansson M, Ljungberg B (2022). Inflammatory response markers and survival prediction in patients with renal cell carcinoma. Scand J Urol. 56(1): 47-52. https://doi.org/10.1080/21681805.2021.1983016 PMID: 34586034
  258. Nomburg J, Bullman S, Nasrollahzadeh D, Collisson EA, Abedi-Ardekani B, Akoko LO, et al. (2022). An international report on bacterial communities in esophageal squamous cell carcinoma. Int J Cancer. 151(11): 1947-1959. https://doi.org/10.1002/ijc.34212 PMID: 35837755
  259. Pakmanesh H, Anvari O, Forey N, Weiderpass E, Malekpourafshar R, Iranpour M, et al. (2022). TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. Int J Mol Sci. 23(22): 14319. https://doi.org/10.3390/ijms232214319 PMID: 36430798
  260. Pastorino R, Sassano M, Danilo Tiziano F, Giraldi L, Amore R, Arzani D, et al. (2022). Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium. Cancer Epidemiol Biomarkers Prev. 31(12): 2237-2243. https://doi.org/10.1158/1055-9965.EPI-22-0376 PMID: 36126276
  261. Perdomo S, Lopez J, Torres-Ibarguen MZ, Puerto-Jimenez DN, de Vries E (2022). Modelling the Reduction in Cancer Incidence After Variations in the Prevalence of Tobacco Consumption in Colombia in the Period 2016-2050. Cancer Control. 29: 10732748221121390. https://doi.org/10.1177/10732748221121390 PMID: 36415920
  262. Petrovic D, Bodinier B, Dagnino S, Whitaker M, Karimi M, Campanella G, et al. (2022). Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking. Eur J Epidemiol. 37(6): 629-640. https://doi.org/10.1007/s10654-022-00877-2 PMID: 35595947
  263. Popovic M, Fiano V, Moirano G, Chiusa L, Conway DI, Garzino Demo P, et al. (2022). The Impact of the COVID-19 Pandemic on Head and Neck Cancer Diagnosis in the Piedmont Region, Italy: Interrupted Time-Series Analysis. Front Public Health. 10: 809283. https://doi.org/10.3389/fpubh.2022.809283 PMID: 35265573
  264. Porta M, Gasull M, Pumarega J, Kiviranta H, Rantakokko P, Raaschou-Nielsen O, et al. (2022). Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Int J Epidemiol. 51(2): 479-490. https://doi.org/10.1093/ije/dyab115 PMID: 34259837
  265. Robbins HA, Cheung LC, Chaturvedi AK, Baldwin DR, Berg CD, Katki HA (2022). Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks. J Thorac Oncol. 17(2): 252-263. https://doi.org/10.1016/j.jtho.2021.10.001 PMID: 34648946
  266. Robbins HA, Ferreiro-Iglesias A, Waterboer T, Brenner N, Nygard M, Bender N, et al. (2022). Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium. J Clin Oncol. 40(31): 3613-3622. https://doi.org/10.1200/JCO.21.01785 PMID: 35700419
  267. Robbins HA, Landy R, Ahluwalia JS (2022). Achieving Equity in Lung Cancer Screening for Black Individuals Requires Innovation to Move Beyond “Equal” Guidelines. JAMA Oncol. 8(4): 1-2. https://doi.org/10.1001/jamaoncol.2021.7252 PMID: 35201279
  268. Robbins HA, Zahed H, Lebrett MB, Balata H, Johansson M, Sharman A, et al. (2022). Explaining differences in the frequency of lung cancer detection between the National Lung Screening Trial and community-based screening in Manchester, UK. Lung Cancer. 171: 61-64. https://doi.org/10.1016/j.lungcan.2022.07.017 PMID: 35917648
  269. Rosenberger A, Muttray N, Hung RJ, Christiani DC, Caporaso NE, Liu G, et al. (2022). Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. Eur J Med Res. 27(1): 14. https://doi.org/10.1186/s40001-022-00638-7 PMID: 35101137
  270. Schmid S, Jiang M, Brown MC, Fares A, Garcia M, Soriano J, et al. (2022). Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data. Cancer Epidemiol Biomarkers Prev. 31(3): 679-687. https://doi.org/10.1158/1055-9965.EPI-21-0747 PMID: 35027437
  271. Sichero L, Tagliabue M, Mota G, Ferreira S, Nunes RAL, Castaneda CA, et al. (2022). Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status. Head Neck. 44(1): 122-133. https://doi.org/10.1002/hed.26912 PMID: 34726297
  272. Simoens C, Gheit T, Ridder R, Gorbaslieva I, Holzinger D, Lucas E, et al. (2022). Accuracy of high-risk HPV DNA PCR, p16((INK4a)) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer. BMC Infect Dis. 22(1): 676. https://doi.org/10.1186/s12879-022-07654-2 PMID: 35933382
  273. Simon J, Brenner N, Reich S, Langseth H, Hansen BT, Ursin G, et al. (2022). Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis. Cancer Epidemiol. 77: 102117. https://doi.org/10.1016/j.canep.2022.102117 PMID: 35121404
  274. Smith-Byrne K, Cerani A, Guida F, Zhou S, Agudo A, Aleksandrova K, et al. (2022). Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements. Cancer Epidemiol Biomarkers Prev. 31(10): 1966-1974. https://doi.org/10.1158/1055-9965.EPI-21-1033 PMID: 35839461
  275. Tran KB, Lang JJ, Compton K, Xu RX, Acheson AR, Henrikson HJ, et al. (2022). The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 400(10352): 563-591. https://doi.org/10.1016/S0140-6736(22)01438-6 PMID: 35988567
  276. Wade KH, Yarmolinsky J, Giovannucci E, Lewis SJ, Millwood IY, Munafo MR, et al. (2022). Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer. Cancer Causes Control. 33(5): 631-652. https://doi.org/10.1007/s10552-022-01562-1 PMID: 35274198
  277. Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, et al. (2022). Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia. Int J Cancer. 151(7): 1033-1046. https://doi.org/10.1002/ijc.34116 PMID: 35579976
  278. Yang JJ, Yu D, White E, Lee DH, Blot W, Robien K, et al. (2022). Prediagnosis Leisure-Time Physical Activity and Lung Cancer Survival: A Pooled Analysis of 11 Cohorts. JNCI Cancer Spectr. 6(2): 11. https://doi.org/10.1093/jncics/pkac009 PMID: 35603841
  279. Yang W, Liu H, Zhang R, Freedman JA, Han Y, Hung RJ, et al. (2022). Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk. NPJ Precis Oncol. 6(1): 48. https://doi.org/10.1038/s41698-022-00281-9 PMID: 35773316
  280. Yao S, Campbell PT, Ugai T, Gierach G, Abubakar M, Adalsteinsson V, et al. (2022). Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting. Cancer Causes Control. 33(8): 1107-1120. https://doi.org/10.1007/s10552-022-01594-7 PMID: 35759080
  281. Yarmolinsky J, Amos CI, Hung RJ, Moreno V, Burrows K, Smith-Byrne K, et al. (2022). Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk. Int J Cancer. 151(12): 2155-2160. https://doi.org/10.1002/ijc.34180 PMID: 35747941
  282. Zhang R, Shen S, Wei Y, Zhu Y, Li Y, Chen J, et al. (2022). A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians. J Thorac Oncol. 17(8): 974-990. https://doi.org/10.1016/j.jtho.2022.04.011 PMID: 35500836

 

 

 
View Key Publications

 

 

Genomic Epidemiology
About Research Publications Related websites Repository Access Policy Personnel
Close Reading Mode
UP